azacitidine plus r-chop in high-risk dlbcl
Published 6 years ago • 202 plays • Length 3:38Download video MP4
Download video MP3
Similar videos
-
1:30
dr. martin on trial of oral azacitidine plus r-chop in high risk dlbcl
-
2:18
azacitidine plus r-chop clinical trial for lymphoma | weill cornell | lymphoma program
-
1:53
oral azacitidine plus r-chop for previously untreated nhl
-
3:48
coalition: glofitamab r-chop or glofitamab pola-r-chp in high-risk dlbcl
-
4:08
utilizing biology to improve on r-chop in dlbcl: targeting ubiquitous markers & mutational analysis
-
1:12
current treatment options for dlbcl besides r-chop chemotherapy
-
4:33
using frontline r-chop and maintenance rituximab in fl
-
2:20
frontmind: tafasitamab lenalidomide r-chop vs r-chop in newly diagnosed high-risk dlbcl
-
1:40
fracture risk in older dlbcl patients after r-chop
-
1:57
r-chop dose intensity and survival outcomes in dlbcl
-
15:16
debate: how should patients with abc type dlbcl be treated today? - r-chop
-
1:24
unmet needs remain in the diffuse large b-cell lymphoma treatment paradigm
-
1:27
atezolizumab plus r-chop in dlbcl: encouraging results
-
2:42
progression after r-chop: what next?
-
0:46
dlbcl prognosis & management in front-line settings #oncology #lungcancer #cancer #2023
-
2:44
polarix study: frontline therapy in dlbcl
-
58:24
update on diffuse large b-cell lymphoma | lrf webinars
-
1:12
smart stop: moving away from r-chop in dlbcl
-
2:03
dr. poeschel on 6 versus 4 cycles of r-chop in frontline dlbcl